Disease / condition

Major Depressive Disorder clinical trials

Free access to 1,198 studies·10+ countries·Updated daily209 recruiting
1,198
Total trials
10+
Countries
10+
Sponsors
209
Recruiting
By phase
N/A546
Phase 3201
Phase 2147
Phase 4136
Phase 163
By status
Completed667
Recruiting209
Not yet recruit...113
Unknown88
Terminated58
Top countries
United States of America438
China87
Canada65
Japan48
Australia26
Top sponsors
H. Lundbeck A/S45
Massachusetts Gene...40
Eli Lilly and Comp...36
Forest Laboratorie...25
Shanghai Mental He...22
Recent trials
Latest clinical trials for Major Depressive Disorder
2015-004905-17
Study to evaluate the efficacy and safety of Paxil® Tablets in children and adolescents with Major Depressive Disorder
GlaxoSmithKline Research & Dev...
2017-001598-18
A study to determine the safety and efficacy of duloxetine in the treatment of children and adolescents with depression.
Eli Lilly and Company Limited
2008-001876-67
Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Pfizer Inc.
2008-002063-13
Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Pfizer Inc
2008-002064-34
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Pfizer Inc.
2017-000211-16
Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
Eli Lilly and Company Limited
2008-002067-14
Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder
Wyeth Research
2008-002066-57
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
Wyeth Research
2021-000567-77
A study to evaluate the safety and tolerability and to assess blood levels of seltorexant in adolescents with Major Depressive Disorder who have not responded well to their current antidepressant and psychotherapy
Janssen-Cilag International NV
NCT06419608·Phase 2Not yet recr...
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Biohaven Therapeutics Ltd.
NCT06360419·Phase 3Recruiting
Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol
Axsome Therapeutics, Inc.United States of America
NCT06357832Not yet recr...
New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)
BrainswayUnited States of America
NCT06345859·Phase 2Recruiting
Regulation of Affect and Physiology in Depression
University of Southern Califor...United States of America
NCT06332261Recruitment ...
Standardized Assessment in Depression Treatment in Routine Psychiatric Services
Karolinska InstitutetSweden
NCT06410599·Phase 2Not yet recr...
Pharmacologic Treatment Augmentation in Chronic Depression
University Hospital TuebingenGermany
NCT06323785Recruiting
Whole-body Hyperthermia for Depression
University of ZurichSwitzerland
NCT06293781Recruiting
Application of the Web-based Acceptance and Commitment Therapy for Depression
Gachon UniversitySouth Korea
NCT06267846·Phase 2Recruiting
A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
Neurocrine BiosciencesUnited States of America
NCT06322420Recruiting
Behavioral Activation for Depression and Habitual Rumination
Ragnar Pétur ÓlafssonIceland
NCT06254612·Phase 2Recruiting
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Sirtsei Pharmaceuticals, Inc.United States of America
About this record

Access comprehensive clinical trial information for Major Depressive Disorder through Pure Global AI's free database. This collection includes 1,198 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 209 trials are actively recruiting participants.

Research for Major Depressive Disorder is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include H. Lundbeck A/S and Massachusetts General Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,198 clinical trials studying Major Depressive Disorder, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include H. Lundbeck A/S, Massachusetts General Hospital, Eli Lilly and Company, among others.